Omar O Abudayyeh

age ~34

from Cambridge, MA

Get Report
Also known as:
  • Omar K Abudayyeh
Related to:
Connected to:

Omar Abudayyeh Phones & Addresses

  • Cambridge, MA
  • Kalamazoo, MI
  • Boston, MA

Resumes

Omar Abudayyeh Photo 1

Mcgovern Institute Fellow

view source
Location:
Kalamazoo, MI
Industry:
Higher Education
Work:
Massachusetts Institute of Technology (Mit)
Mcgovern Institute Fellow
Broad Institute May 2014 - Jan 2019
Medical Doctor and Phd Student In Feng Zhang's Lab
Sherlock Biosciences May 2014 - Jan 2019
Co-Founder
Modalyst Apr 2012 - Mar 2013
Co-Founder and Vice President of Engineering
Education:
Harvard Medical School 2012 - 2019
Doctor of Medicine, Doctorates, Doctor of Philosophy, Biomedical Engineering, Bioengineering Massachusetts Institute of Technology 2014 - 2018
Doctorates, Doctor of Philosophy, Physics, Medical Engineering, Philosophy Massachusetts Institute of Technology 2008 - 2012
Bachelors, Bachelor of Science, Biological Engineering, Mechanical Engineering Harvard University
Portage Central High School
Kalamazoo Area Mathematics and Science Center
Skills:
Genetics
Biomedical Engineering
Matlab
Nanotechnology
Python
Biotechnology
Lifesciences
Systems Biology
Interests:
Genetics
The Killers (Band)
Systems Biology
Molecular Engineering
Coldplay (Band)
Kvcc
Cancer
Nanotechnology
Omar Abudayyeh Photo 2

Student At Massachusetts Institute Of Technology

view source
Location:
Greater Boston Area
Industry:
Medical Devices
Education:
Massachusetts Institute of Technology 2008 - 2012

Us Patents

  • Novel Crispr Enzymes And Systems

    view source
  • US Patent:
    20220364071, Nov 17, 2022
  • Filed:
    Jul 31, 2019
  • Appl. No.:
    17/264340
  • Inventors:
    - Cambridge MA, US
    Jonathan Gootenberg - Cambridge MA, US
    Omar Abudayyeh - Cambridge MA, US
  • Assignee:
    THE BROAD INSTITUTE, INC. - Cambridge MA
    MASSACHUSETTS INSTITUTE OF TECHNOLOGY - Cambridge MA
    PRESIDENT AND FELLOWS OF HARVARD COLLEGE - Cambridge MA
  • International Classification:
    C12N 9/78
    C12N 9/22
    C12N 15/11
    C12Q 1/6823
    C12Q 1/6851
  • Abstract:
    The present disclosure provides for systems, methods, and compositions for targeting nucleic acids. In particular, the invention provides mutated Cas13 proteins and their use in modifying target sequences as well as mutated Cas13 nucleic acid sequences and vectors encoding mutated Cas13 proteins and vector systems or CRISPR-Cas13 systems.

  • Crispr Effector System Based Coronavirus Diagnostics

    view source
  • US Patent:
    20220325334, Oct 13, 2022
  • Filed:
    Apr 27, 2022
  • Appl. No.:
    17/731019
  • Inventors:
    - Cambridge MA, US
    Omar Abudayyeh - Cambridge MA, US
    Julia Joung - Cambridge MA, US
    Alim Ladha - Cambridge MA, US
    Guilhem Faure - Cambridge MA, US
  • Assignee:
    THE BROAD INSTITUTE, INC. - Cambridge MA
    MASSACHUSETTS INSTITUTE OF TECHNOLOGY - Cambridge MA
  • International Classification:
    C12Q 1/6844
    C12N 9/22
    C12Q 1/6806
    C12N 9/12
    C12N 9/78
    B01L 3/00
    B01L 7/00
  • Abstract:
    Systems and methods for rapid diagnostics related to the use of CRISPR effector systems and optimized guide sequences for detection of coronavirus, including multiplex lateral flow diagnostic devices and methods of use, are provided.

  • Novel Crispr Enzymes And Systems

    view source
  • US Patent:
    20220195503, Jun 23, 2022
  • Filed:
    Dec 17, 2021
  • Appl. No.:
    17/554333
  • Inventors:
    - Cambridge MA, US
    Omar O. ABUDAYYEH - Cambridge MA, US
    Ian SLAYMAKER - Cambridge MA, US
  • Assignee:
    The Broad Institute, Inc. - Cambridge MA
    Massachusetts Institute of Technology - Cambridge MA
    President and Fellows of Harvard College - Cambridge MA
  • International Classification:
    C12Q 1/6832
    C12N 15/11
    C12N 9/22
    C12N 15/113
    C12Q 1/6816
  • Abstract:
    The invention provides for systems, methods, and compositions for targeting nucleic acids. In particular, the invention provides non-naturally occurring or engineered DNA-targeting systems comprising a novel DNA-targeting CRISPR effector protein and at least one targeting nucleic acid component like a guide RNA. Methods for making and using and uses of such systems, methods, and compositions and products from such methods and uses are also disclosed and claimed.

  • Novel Crispr Enzymes And Systems

    view source
  • US Patent:
    20230074840, Mar 9, 2023
  • Filed:
    Dec 17, 2021
  • Appl. No.:
    17/554314
  • Inventors:
    - Cambridge MA, US
    Omar O. ABUDAYYEH - Cambridge MA, US
    Ian SLAYMAKER - Cambridge MA, US
  • Assignee:
    The Broad Institute, Inc. - Cambridge MA
    Massachusetts Institute of Technology - Cambridge MA
    President and Fellows of Harvard College - Cambridge MA
  • International Classification:
    C12Q 1/6832
    C12N 15/11
    C12N 9/22
    C12N 15/113
    C12Q 1/6816
  • Abstract:
    The invention provides for systems, methods, and compositions for targeting nucleic acids. In particular, the invention provides non-naturally occurring or engineered DNA-targeting systems comprising a novel DNA-targeting CRISPR effector protein and at least one targeting nucleic acid component like a guide RNA. Methods for making and using and uses of such systems, methods, and compositions and products from such methods and uses are also disclosed and claimed.

  • Novel Crispr Enzymes And Systems

    view source
  • US Patent:
    20210348156, Nov 11, 2021
  • Filed:
    Apr 30, 2021
  • Appl. No.:
    17/246460
  • Inventors:
    - Cambridge MA, US
    - New Brunswick NJ, US
    - Moscow, RU
    - Bethesda MD, US
    Leonid Minakhin - New Brunswick MD, US
    Kira S. Makarova - Bethesda MD, US
    Silvana Konermann - Cambridge MA, US
    Julia Joung - Cambridge MA, US
    Jonathan S. Gootenberg - Cambridge MA, US
    Omar O. Abudayyeh - Cambridge MA, US
  • International Classification:
    C12N 15/10
    C12N 15/11
    C12N 9/22
    C12N 15/82
    A61K 48/00
  • Abstract:
    The invention provides for systems, methods, and compositions for targeting nucleic acids. In particular, the invention provides non-naturally occurring or engineered DNA or RNA-targeting systems comprising a novel DNA or RNA-targeting CRISPR effector protein and at least one targeting nucleic acid component like a guide RNA.

  • Novel Crispr Enzymes And Systems

    view source
  • US Patent:
    20210348157, Nov 11, 2021
  • Filed:
    Apr 30, 2021
  • Appl. No.:
    17/246466
  • Inventors:
    - Cambridge MA, US
    - New Brunswick NJ, US
    - Moscow, RU
    - Bethesda MD, US
    Leonid Minakhin - New Brunswick MD, US
    Kira S. Makarova - Bethesda MD, US
    Silvana Konermann - Cambridge MA, US
    Julia Joung - Cambridge MA, US
    Jonathan S. Gootenberg - Cambridge MA, US
    Omar O. Abudayyeh - Cambridge MA, US
  • International Classification:
    C12N 15/10
    C12N 15/11
    C12N 9/22
    C12N 15/82
    A61K 48/00
  • Abstract:
    The invention provides for systems, methods, and compositions for targeting nucleic acids. In particular, the invention provides non-naturally occurring or engineered DNA or RNA-targeting systems comprising a novel DNA or RNA-targeting CRISPR effector protein and at least one targeting nucleic acid component like a guide RNA.

  • Novel Type V Crispr-Cas Systems And Use Thereof

    view source
  • US Patent:
    20210292721, Sep 23, 2021
  • Filed:
    Jun 5, 2020
  • Appl. No.:
    16/894678
  • Inventors:
    Feng Zhang - Cambridge MA, US
    Jonathan Gootenberg - Cambridge MA, US
    Omar Abudayyeh - Cambridge MA, US
    Julia Joung - Cambridge MA, US
    Alim Ladha - Cambridge MA, US
    Guilhem Faure - Cambridge MA, US
  • International Classification:
    C12N 9/22
    C12N 9/12
    C12N 9/78
  • Abstract:
    Engineered or non-naturally occurring systems and compositions comprising a novel Cas12b and a guide molecule. Also provided include methods of use the systems and compositions, including in treating and diagnosing diseases.

  • Rapid Diagnostics

    view source
  • US Patent:
    20210292823, Sep 23, 2021
  • Filed:
    Jun 5, 2020
  • Appl. No.:
    16/894664
  • Inventors:
    Feng Zhang - Cambridge MA, US
    Jonathan Gootenberg - Cambridge MA, US
    Omar Abudayyeh - Cambridge MA, US
    Julia Joung - Cambridge MA, US
    Alim Ladha - Cambridge MA, US
    Guilhem Faure - Cambridge MA, US
  • International Classification:
    C12Q 1/6844
    B01L 7/00
    B01L 3/00
  • Abstract:
    Systems and methods for rapid diagnostics related to the use of isothermal amplification reagents for detection of microbial species, including coronavirus, and methods of use, are provided.

Facebook

Omar Abudayyeh Photo 3

Omar Abudayyeh

view source
Omar Abudayyeh Photo 4

Omar Abudayyeh

view source

Googleplus

Omar Abudayyeh Photo 5

Omar Abudayyeh

Education:
Massachusetts Institute of Technology - Bioengineering/Mechanical Engineering
Omar Abudayyeh Photo 6

Omar Abudayyeh

News

License Plates Of Mit

License plates of MIT

view source
  • Omar Abudayyeh 12, PhD 18, a recent McGovern Fellow at the McGovern Institute for Brain Research at MIT who is now an assistant professor at Harvard Medical School, shares an equally riveting story about his vanity plate, CRISPR, which adorns his sport utility vehicle.
  • Date: Jul 22, 2024
  • Category: Science
  • Source: Google
Crispr 2.0: A New Wave Of Gene Editors Heads For Clinical Trials

CRISPR 2.0: a new wave of gene editors heads for clinical trials

view source
  • This opens the door to replacing entire genes, says Omar Abudayyeh, a biological engineer at the Massachusetts Institute of Technology in Cambridge thereby making it easier to develop a therapy to treat genetic disorders, such as cystic fibrosis, that can be caused by many different mutations in
  • Date: Dec 07, 2023
  • Category: Health
  • Source: Google
Thousands Of Programmable Dna-Cutters Found In Algae, Snails, And Other Organisms

Thousands of programmable DNA-cutters found in algae, snails, and other organisms

view source
  • RNA-guided biology is what lets you make programmable tools that are really easy to use. So the more we can find, the better, says McGovern Fellow Omar Abudayyeh, who led the research with McGovern Fellow Jonathan Gootenberg.
  • Date: Oct 13, 2023
  • Category: Science
  • Source: Google

CRISPR-based Covid-19 test could be a simple, cheap diagnostic

view source
  • ing in the U.S. It takes about an hour to get results, requires minimal handling, and in preliminary studies has been highly accurate, Zhang told STAT. He and his colleagues, led by the McGoverns Jonathan Gootenberg and Omar Abudayyeh, released the protocol on their STOPCovid.science website.
  • Date: May 05, 2020
  • Category: More news
  • Source: Google

Youtube

ELIAS SMEIR ARABIC POETRY MOTHER'S DAY

ELIAS SMEIR ARABIC POETRY MOTHER'S DAY

I present this poem to the soul of my late beloved mother Dalal. Dalal...

  • Category:
    Entertainment
  • Uploaded:
    20 Mar, 2009
  • Duration:
    7m 22s
Get Report for Omar O Abudayyeh from Cambridge, MA, age ~34
Control profile